Favipiravir CAS 259793-96-9 T-705 Purity ≥99.0% (HPLC) COVID-19 API Factory High Quality

Tlhaloso e Khutšoanyane:

Lebitso la Lik'hemik'hale: Favipiravir;T-705

CAS: 259793-96-9

Ponahalo: Phofo e tšoeu ho isa ho e tšoeu

Bohloeki: ≥99.0% (HPLC)

Kalafong ea Influenza Virus Infections le COVID-19

API Boleng bo Phahameng, Tlhahiso ea Khoebo

Inquiry: alvin@ruifuchem.com


Lintlha tsa Sehlahisoa

Lihlahisoa tse Amanang

Li-tag tsa Sehlahisoa

Tlhaloso:

Lintho tsa Lik'hemik'hale:

Lebitso la Lik'hemik'hale Favipiravir
Litlhaloso tse tšoanang T-705;6-Fluoro-3-Hydroxy-2-Pyrazinecarboxamide
Nomoro ea CAS 259793-96-9
Nomoro ea KAtse RF-API18
Boemo ba Setoko Ka Setokong, Phatlalatso e Eketsehile ho fihla ho Makholo a Lik'hilograma
Foromo ea limolek'hule C5H4FN3O2
Boima ba Molek'hule 157.1
Brand Ruifu Chemical

Litlhaloso:

Ntho Litlhaloso
Ponahalo Phofo e tšoeu ho isa ho e tšoeu
Boitsebiso ba 1H-NMR E tsamaellana le sebopeho se sisintsoeng
Boitsebiso ba HPLC Nako ea ho boloka tlhōrō e kholo ho lokisetsong ea mohlala e lokela ho lumellana le nako ea ho boloka tlhōrō ea tlhoro ea tlhoro ea litšupiso tse tloaelehileng.
Boitshupo Mmisa Mass Spectrum e lumellana le sebopeho se reriloeng
Melting Point 188.0 ℃-193.0 ℃
Lintho Tse Amanang
(Tlhahiso ea Sebaka)
Tšilafalo efe kapa efe e le 'Ngoe: ≤0.10% (HPLC)
Kakaretso ea Litšila: ≤1.0% (HPLC)
Mokhoa oa Bohloeki / Analysis ≥99.0% (HPLC)
Mongobo (KF) ≤0.50%
Masalla a ho Ignition ≤0.10%
Litšepe tse boima ≤20ppm
Metsoako ea Masala
Methanol ≤3000ppm
Isopropanol ≤5000ppm
n-Heptane ≤5000ppm
Ethanol ≤5000ppm
Tekanyetso ea Teko Maemo a Khoebo
Tšebeliso Motsoako o sebetsang oa Pharmaceutical (API);Kalafo ea COVID-19

Sephutheloana le Bobolokelo:

Sephutheloana: Botlolo, Aluminium foil bag, 25kg/Cardboard drum, kapa ho latela tlhoko ea moreki.

Boemo ba polokelo:Boloka ka lijaneng tse koetsoeng sebakeng se phodileng le se omileng;Sireletsa khanya, mongobo le ho hlaseloa ke likokoanyana.

Melemo:

1

LBH:

Kopo:

Favipiravir (T-705) (CAS 259793-96-9) ke e 'ngoe ea metsoako e 5 e khothaletsoang ke WHO bakeng sa lipatlisiso tsa kalafo ea COVID-19.Favipiravir ke inhibitor e ikhethileng ea RNA polymerase e itšetlehileng ka vaerase e nang le ts'ebetso khahlano le livaerase tse ngata tsa RNA, vaerase ea ntaramane, vaerase ea West Nile, vaerase ea yellow fever, vaerase ea lefu la leoto le molomo hammoho le li-flaviviruses tse ling, arenaviruses, bunyaviruses le alphaviruses.Favipiravir ke setlhare se thibelang likokoana-hloko se pharalletseng se ileng sa hlakisoa ke Drug Controller General of India (DCGI) bekeng e fetileng bakeng sa ts'ebeliso ea "thibelo ea tšohanyetso" har'a bakuli ba Covid-19.Favipiravir e qalile ho etsoa bofelong ba lilemo tsa bo-1990 ke k'hamphani eo hamorao e ileng ea rekoa ke feme ea Japane ea Fujifilm e le karolo ea phetoho ea eona ho tloha khoebong ea lifoto ho ea tlhokomelong ea bophelo bo botle.Kamora ho lekoa khahlano le mefuta e mengata ea livaerase, setlhare se ile sa amoheloa Japane ka 2014 bakeng sa tšebeliso ea tšohanyetso khahlano le mafu a seoa kapa ho alafa mefuta e mecha ea ntaramane.

Ngola molaetsa wa hao mona mme o re romele wona